MetLife Investment Management, LLC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 166 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$132,196
-34.4%
30,6010.0%0.00%
-50.0%
Q2 2023$201,661
-2.9%
30,6010.0%0.00%0.0%
Q1 2023$207,780
-8.1%
30,6010.0%0.00%0.0%
Q4 2022$226,141
-25.2%
30,6010.0%0.00%
-33.3%
Q3 2022$302,338
-9.4%
30,6010.0%0.00%0.0%
Q2 2022$333,551
-3.6%
30,6010.0%0.00%
+50.0%
Q1 2022$346,097
+12.5%
30,601
+56.0%
0.00%
-33.3%
Q4 2021$307,712
+9.9%
19,612
+20.1%
0.00%0.0%
Q3 2021$279,913
-39.1%
16,331
-23.6%
0.00%
-25.0%
Q2 2021$459,970
+43.2%
21,3840.0%0.00%
+33.3%
Q1 2021$321,188
+0.4%
21,384
-12.1%
0.00%0.0%
Q4 2020$319,775
+36.0%
24,3360.0%0.00%0.0%
Q3 2020$235,086
-15.6%
24,3360.0%0.00%0.0%
Q2 2020$278,404
+10.4%
24,3360.0%0.00%
-25.0%
Q1 2020$252,121
-36.9%
24,3360.0%0.00%0.0%
Q4 2019$399,354
+23.6%
24,3360.0%0.00%0.0%
Q3 2019$323,182
-5.7%
24,3360.0%0.00%0.0%
Q2 2019$342,894
-23.4%
24,3360.0%0.00%
-20.0%
Q1 2019$447,782
-29.6%
24,3360.0%0.01%
-37.5%
Q4 2018$635,900
+13.9%
24,3360.0%0.01%
+33.3%
Q3 2018$558,511
+20.4%
24,3360.0%0.01%
+20.0%
Q2 2018$464,000
+35.7%
24,336
+20.0%
0.01%
+25.0%
Q1 2018$342,000
+11.0%
20,2730.0%0.00%
+33.3%
Q4 2017$308,00020,2730.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,532,000$27,423,0003.23%
Stonepine Capital Management, LLC 300,000$5,370,0003.16%
Palo Alto Investors LP 4,155,670$74,386,0003.13%
GREAT POINT PARTNERS LLC 497,531$8,906,0001.73%
Avoro Capital Advisors LLC 988,270$17,690,0001.37%
UNIVERSITY OF NOTRE DAME DU LAC 157,781$2,824,0000.79%
Birchview Capital, LP 68,000$1,217,0000.63%
Cheyne Capital Management (UK) LLP 74,000$1,323,0000.48%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 352,604$6,311,0000.43%
361 CAPITAL LLC 119,554$2,140,0000.41%
View complete list of VANDA PHARMACEUTICALS INC shareholders